Sugi Predict

Sugi Predict / Compounds / SCHEMBL11058910

SCHEMBL11058910

SCHEMBL11058910

CC(=O)CC(C)=O.CC(=O)CC(C)=O.[O-2].[O-2].[O-2].[O-2].[O-2].[V+5].[V+5]

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MGAM O43451 1/20 0.50
▸ GAA P10253 1/20 0.50
▸ SI P14410 1/20 0.50
▸ MGAM2 Q2M2H8 1/20 0.50
▸ ALDH1A1 P00352 5/20 0.47
▸ TDP1 Q9NUW8 2/20 0.47
▸ HTT P42858 2/20 0.45
▸ TRPA1 O75762 1/20 0.44
▸ KDM4E B2RXH2 3/20 0.43
▸ KDM6B O15054 1/20 0.43
▸ KDM5C P41229 1/20 0.43
▸ EGLN1 Q9GZT9 1/20 0.43
▸ PHF8 Q9UPP1 1/20 0.43
▸ KDM2A Q9Y2K7 1/20 0.43
▸ LMNA P02545 4/20 0.39
▸ CA2 P00918 1/20 0.38
▸ PTGS1 P23219 1/20 0.38
▸ MMP12 P39900 1/20 0.38
▸ SLC15A2 Q16348 1/20 0.37
▸ TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9791280 0.92 MGAM (0.50) MGAMGAASIMGAM2ALDH1A1
Zinc Ion SCHEMBL28870514 0.92 — —
SCHEMBL16879073 0.92 — —
SCHEMBL6415978 0.92 MGAM (0.50) MGAMGAASIMGAM2ALDH1A1
SCHEMBL31044633 0.92 MGAM (0.50) MGAMGAASIMGAM2ALDH1A1
SCHEMBL2128645 0.91 MGAM (0.56) MGAMGAASIMGAM2ALDH1A1
SCHEMBL10389469 0.91 MGAM (0.56) MGAMGAASIMGAM2ALDH1A1
SCHEMBL1608 0.91 — —
Water SCHEMBL23151837 0.87 MGAM (0.53) MGAMGAASIMGAM2ALDH1A1
SCHEMBL21404935 0.87 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4273133-A1 METHOD FOR PREPARING 6-HYDROXY-6 (HYDROXYMETHYL)-2H-PYRAN-3(6H)-ONE BY MEANS OF CATALYTIC OXIDATION Ningbo Institute of Materials Technology & Engineering, Chinese Academy of Sciences (CN) 2023-11-08 — — EP disclosed
US-11479569-B2 Compound, photopolymerization initiator, photocurable composition and cured product thereof, and photocurable ink and print using the same DIC CORPORATION (JP) 2022-10-25 — — US disclosed
CN-112552434-B Multi-center supported catalyst and preparation method and application thereof 中国石油天然气股份有限公司 2022-08-02 — — CN disclosed
CN-113087018-B Preparation method of vanadium trioxide nano material rich in vanadium holes 中国科学技术大学 2022-07-15 — — CN disclosed
CN-111454111-B Vanadium-carbon composite combustion catalyst for propellant and preparation method thereof 西安近代化学研究所 2021-10-01 — — CN disclosed
CN-113087018-A Preparation method of vanadium trioxide nano material rich in vanadium holes 中国科学技术大学 2021-07-09 — — CN disclosed
CN-112552434-A Multi-center supported catalyst and preparation method and application thereof 中国石油天然气股份有限公司 2021-03-26 — — CN disclosed
EP-3483161-B1 INTERMEDIATES USED TO MAKE ENTECAVIR ZHEJIANG AUSUN PHARMACEUTICAL CO LTD (CN) 2021-03-03 — — EP disclosed
US-20200270286-A1 COMPOUND, PHOTOPOLYMERIZATION INITIATOR, PHOTOCURABLE COMPOSITION AND CURED PRODUCT THEREOF, AND PHOTOCURABLE INK AND PRINT USING THE SAME DIC CORPORATION (JP) 2020-08-27 — — US disclosed
CN-111454111-A Vanadium-carbon composite combustion catalyst for propellant and preparation method thereof 西安近代化学研究所 2020-07-28 — — CN disclosed
EP-3483161-A1 INTERMEDIATES USED TO MAKE ENTECAVIR Zhejiang Ausun Pharmaceutical Co., Ltd. (CN) 2019-05-15 — — EP disclosed
WO-2019071428-A1 COMPOUND, PHOTOPOLYMERIZATION INITIATOR, PHOTOCURABLE COMPOSITION AND CURED PRODUCT THEREOF, AND PHOTOCURABLE INK AND PRINT USING THE SAME DIC CORPORATION (JP) 2019-04-18 — — WO disclosed
EP-2594569-B1 ENTECAVIR SYNTHESIS METHOD AND INTERMEDIATE COMPOUND THEREOF ZHEJIANG AUSUN PHARMACEUTICAL CO LTD (CN) 2019-03-20 — — EP disclosed
US-9309249-B2 Entecavir synthesis method and intermediate compound thereof Zhejiang Ausun Pharmaceutical Co., Ltd (CN) 2016-04-12 — — US disclosed
US-20130217879-A1 ENTECAVIR SYNTHESIS METHOD AND INTERMEDIATE COMPOUND THEREOF AUSUN PHARMATECH. CO., LTD. (CN) 2013-08-22 — — US disclosed
EP-2594569-A1 ENTECAVIR SYNTHESIS METHOD AND INTERMEDIATE COMPOUND THEREOF Zhejiang Ausun Pharmaceutical Co., Ltd. (CN) 2013-05-22 — — EP disclosed
US-4424142-A VANADIUM SULFIDE, MAGNESIUM SILICATE CLAY SUPPORT CHIYODA CHEMICAL ENGINEERING & CONSTRUCTION CO., LTD. (JP) 1984-01-03 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200270286-A1 COMPOUND, PHOTOPOLYMERIZATION INITIATOR, PHOTOCURABLE COMPOSITION AND CURED PRODUCT THEREOF, AND PHOTOCURABLE INK AND PRINT USING THE SAME TYR, CRY1, CCNA1 MGAM 4558/4885GAA 3656/4885SI 4820/4885
US-20130217879-A1 ENTECAVIR SYNTHESIS METHOD AND INTERMEDIATE COMPOUND THEREOF ENTPD5, ENTPD8, ENTPD1 MGAM 2584/4885GAA 1295/4885SI 62/4885
US-11479569-B2 Compound, photopolymerization initiator, photocurable composition and cured product thereof, and photocurable ink and print using the same TYR, CRY1, CCNA1 MGAM 4558/4885GAA 3656/4885SI 4820/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.